晨光生物(300138.SZ):近日取得3項專利證書
格隆匯11月29日丨晨光生物(300138.SZ)公佈,公司於近日正式取得了國家知識產權局頒發的三項專利證書,其中一項專利同時獲日本專利管理部門授權,分別為一種番茄紅素微囊粉及其製備方法、一種快速製備高含量葉黃素的工業化方法及其製品、一種流體濁度實時監測裝置。
“一種番茄紅素微囊粉及其製備方法”涉及一種色素的微囊技術,本發明工藝簡單,綠色環保,生產成本低,適合大規模製備番茄紅素微囊粉。“一種快速製備高含量葉黃素的工業化方法及其製品”屬於植物功能性成分提取的技術領域,本發明的方法步驟簡單,所得的葉黃素含量和得率高,適用於工業化的大規模應用。“一種流體濁度實時監測裝置”涉及植物提取行業,本實用新型結構簡單,成本低廉,安裝方便,環境光度耐性強,可以有效地實時監控流體渾濁度,尤其適用於防爆場合。
以上專利主要是克服現有技術中的不足,對現有工藝進行的改進和提升,其中“一種番茄紅素微囊粉及其製備方法”及“一種流體濁度實時監測裝置”已應用於生產,其他專利將陸續應用於生產經營。上述專利的取得,有利於發揮公司的自主知識產權優勢,形成持續創新機制。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.